Literature DB >> 35341663

Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258].

Alice Baggi1, Pietro Quaglino2, Marco Rubatto2, Roberta Depenni3, Michele Guida4, Paolo Antonio Ascierto5, Claudia Trojaniello5, Paola Queirolo6, Maristella Saponara7, Ketty Peris8, Francesco Spagnolo9, Luca Bianchi10, Federica De Galitiis11, Maria Concetta Potenza12, Ilaria Proietti12, Riccardo Marconcini13, Andrea Botticelli14, Vito Barbieri15, Lisa Licitra16, Salvatore Alfieri17, Corrado Ficorella18, Alessio Cortellini19, Maria Concetta Fargnoli18, Teresa Troiani20, Luca Tondulli21, Manuel Zamparini1, Paolo Bossi22.   

Abstract

Entities:  

Year:  2022        PMID: 35341663     DOI: 10.1016/j.ejca.2022.02.027

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective survey.

Authors:  Quentin Samaran; Romain Samaran; Ernestine Ferreira; Naeda Haddad; Antoine Fottorino; Hervé Maillard; Brigitte Dreno; Nicolas Meyer; David Azria; Eve Maubec; Caroline Gaudy-Marqueste; Nicolas Molinari; Pierre-Emmanuel Stoebner; Olivier Dereure
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-12       Impact factor: 4.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.